NEWS

Improving Harm Reduction

Share

Globally, people who inject drugs (PWID) are disproportionately affected by HIV, being 28 times more likely to live with the virus than the general population. They also face higher rates of hepatitis C (HCV) and tuberculosis (TB).

South Africa has made considerable progress in harm reduction and evidence-based approaches to drug use, however substantial challenges remain. The persistently high rates of hepatitis C among people who inject and use drugs highlight the ongoing need for action. In light of these critical health challenges, the 13th International Conference on Health and Hepatitis in Substance Users (INHSU 2025) will be held in Cape Town. Taking place from 14-17 October 2025 at the Century City Conference Centre.

The INHSU 2025 aims to bring together global experts to strengthen advocacy efforts, encourage government support for harm reduction initiatives in the region, and foster discussions on effective strategies to address these pressing issues.

For more information about the conference visit the INHSU website

Watch: Connecting with care – South Africa

Championing Men’s Health

In communities across South Africa, NACOSA is working to engage adolescent boys and young men in vital conversations about health, mental well-being, and social issues. Through these engagements, NACOSA tackles

Read More »